Literature DB >> 12536218

Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology.

Claude-Alain Maurage1, Nicolas Sergeant, Marie-Magdeleine Ruchoux, Jean-Jacques Hauw, André Delacourte.   

Abstract

Microtubule-associated protein tau is abnormally phosphorylated in many neurodegenerative disorders, and is the major component of neurofibrillary degeneration, a degenerating process with many biochemical phenotypes. The serine 199 (S199) residue of tau is phosphorylated at early and late stages of Alzheimer's disease (AD). We studied the immunohistochemical distribution of this phosphorylated epitope in AD and other neurodegenerative disorders, as well as in controls of different ages. The phosphorylated S199 (S199P) epitope was observed in tau lesions from numerous diseases with neurofibrillary degeneration. This epitope was found to be abundantly expressed in the hippocampus formation in childhood and in young adult brain samples, and more specifically in subsets of neurons vulnerable to neurodegeneration. Interestingly, our data suggests that S199P is particularly resistant to phosphatase activity occurring during post-mortem delays. We suggest a peculiar and important role of the S199 residue as a qualitative indicator of the normal and pathological phosphorylation status of tau proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12536218     DOI: 10.1007/s00401-002-0608-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  17 in total

1.  Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.

Authors:  Brian R Hoover; Miranda N Reed; Jianjun Su; Rachel D Penrod; Linda A Kotilinek; Marianne K Grant; Rose Pitstick; George A Carlson; Lorene M Lanier; Li-Lian Yuan; Karen H Ashe; Dezhi Liao
Journal:  Neuron       Date:  2010-12-22       Impact factor: 17.173

2.  Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer's disease.

Authors:  Tanusree Sen; Pampa Saha; Tong Jiang; Nilkantha Sen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-12       Impact factor: 11.205

3.  Blockade of NR2A-containing NMDA receptors induces Tau phosphorylation in rat hippocampal slices.

Authors:  Julie Allyson; Eve Dontigny; Yves Auberson; Michel Cyr; Guy Massicotte
Journal:  Neural Plast       Date:  2010-05-20       Impact factor: 3.599

4.  Tau phosphorylation sites work in concert to promote neurotoxicity in vivo.

Authors:  Michelle L Steinhilb; Dora Dias-Santagata; Tudor A Fulga; Daniel L Felch; Mel B Feany
Journal:  Mol Biol Cell       Date:  2007-10-10       Impact factor: 4.138

5.  Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro.

Authors:  Robert A Whittington; László Virág; Maud Gratuze; Franck R Petry; Anastasia Noël; Isabelle Poitras; Geoffrey Truchetti; François Marcouiller; Marie-Amélie Papon; Noura El Khoury; Kevin Wong; Alexis Bretteville; Françoise Morin; Emmanuel Planel
Journal:  Neurobiol Aging       Date:  2015-05-09       Impact factor: 4.673

6.  Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice.

Authors:  Courtney K Walker; Kelsey M Greathouse; Benjamin D Boros; Emily H Poovey; Kelsey R Clearman; Raksha Ramdas; Hamad M Muhammad; Jeremy H Herskowitz
Journal:  Neuroscience       Date:  2020-12-17       Impact factor: 3.590

7.  Air pollution & the brain: Subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative disease.

Authors:  Shannon Levesque; Michael J Surace; Jacob McDonald; Michelle L Block
Journal:  J Neuroinflammation       Date:  2011-08-24       Impact factor: 8.322

Review 8.  Maintenance of synaptic stability requires calcium-independent phospholipase A₂ activity.

Authors:  Julie Allyson; Xiaoning Bi; Michel Baudry; Guy Massicotte
Journal:  Neural Plast       Date:  2012-05-20       Impact factor: 3.599

9.  Hyperphosphorylation and cleavage at D421 enhance tau secretion.

Authors:  Vanessa Plouffe; Nguyen-Vi Mohamed; Jessica Rivest-McGraw; Johanne Bertrand; Michel Lauzon; Nicole Leclerc
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

10.  A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies.

Authors:  Jie Zheng; Na Tian; Fei Liu; Yidian Zhang; Jingfen Su; Yang Gao; Mingmin Deng; Linyu Wei; Jingwang Ye; Honglian Li; Jian-Zhi Wang
Journal:  Signal Transduct Target Ther       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.